Comparative bioavailability (BA) or bioequivalence (BE) studies might be one of the most common clinical trials for both new drug innovators and the generic manufactures. Like other studies with PK endpoints, selecting an adequate and robust sampling time is essential...
All
Sponsors
A Simulation-based Decision Guide to Navigate Missing Data in Clinical Studies
Missing Data – A Common But Critical Issue in Clinical Studies In part one, of this two part blog series, we will discuss the missing data issue in clinical studies. In bioavailability (BA) and bioequivalence (BE) studies with pharmacokinetic endpoints, the occurrence...
Clinical Research Coordinator (CRC) Journeys at BioPharma Services
This blog unfolds the varied journeys of three individuals at BioPharma Services, each narrating their unique experience in the clinical research landscape. From the initial steps as interns to evolving into Clinical Research Coordinators, their stories reflect the...
Crossing Clinical Frontiers: My Transition from CAMH to Phase 1 Studies Manager
In a world where our beginnings often predetermine our paths, my story is a testament to the power of perseverance, adaptability, and an unyielding commitment to excellence. Born into the confines of traditional Chinese customs, my journey has been about challenging...
The Success Story of Repeat Business from a CRO Sponsor
Every successful Clinical Research Organization (CRO), whether a small startup or a large corporation, relies heavily on the support and collaboration of sponsors. These CRO sponsors serve a crucial role by offering not only financial backing but also valuable...
Strategies for Successful Open-Label Clinical Trials
Designing efficient and safe clinical trials that generate reliable and accurate data is indispensable for the success of clinical drug development programs. Even though randomized, double-blind clinical trials, which reduce the risk of bias, are a preferred clinical...